• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

罕见病例报告:以直肠和宫颈淋巴结转移为首发症状的非肿块型浸润性导管癌。

Rare case report: non-mass invasive ductal carcinoma presenting with rectal and cervical lymph node metastasis as the initial symptom.

作者信息

Zhang Qiong, Xiong Zhifeng, Gao Yuan, Zeng Min, Yang Huachao, Lyu Gang

机构信息

Department of Breast, The Third Affiliated Hospital of Beijing University of Chinese Medicine, Beijing, China.

Department of Breast, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, China.

出版信息

Front Oncol. 2025 Jun 25;15:1606116. doi: 10.3389/fonc.2025.1606116. eCollection 2025.

DOI:10.3389/fonc.2025.1606116
PMID:40636692
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12237999/
Abstract

It is uncommon for breast cancer to present with distant metastasis as the initial symptom. This study reported a 67-year-old female patient with breast non-mass invasive ductal carcinoma, who sought medical attention due to abdominal distention, lower abdominal pain, constipation, hematochezia, and left-sided neck swelling. After a thorough examination, pathology confirmed the diagnosis of breast invasive ductal carcinoma, along with cervical lymph node and rectal metastasis. The non-specific breast symptoms in this case posed challenges for the early diagnosis of breast cancer. This also suggests that for breast cancer patients without a history of gastrointestinal disease, the presence of changes in bowel habits should raise suspicion for metastatic lesions. Imaging combined with biopsy pathology plays an important role in the diagnosis and treatment of non-mass breast cancer. This case also underscores the importance of breast health awareness and routine breast cancer screening among women, both for clinical practice and public health initiatives. Notably, early identification and diagnosis of non-mass breast cancer, coupled with the development of personalized treatment plans through multidisciplinary collaboration, are essential for enhancing treatment efficacy.

摘要

乳腺癌以远处转移作为首发症状并不常见。本研究报告了一名67岁女性患者,患有乳腺非肿块型浸润性导管癌,因腹胀、下腹痛、便秘、便血和左侧颈部肿胀前来就医。经过全面检查,病理确诊为乳腺浸润性导管癌,伴有颈部淋巴结和直肠转移。该病例中乳腺的非特异性症状给乳腺癌的早期诊断带来了挑战。这也表明,对于无胃肠道疾病史的乳腺癌患者,肠道习惯改变应引起对转移病灶的怀疑。影像学检查结合活检病理在非肿块型乳腺癌的诊断和治疗中起着重要作用。该病例还强调了女性乳腺健康意识和乳腺癌常规筛查的重要性,这对于临床实践和公共卫生举措都很重要。值得注意的是,非肿块型乳腺癌的早期识别和诊断,以及通过多学科协作制定个性化治疗方案,对于提高治疗效果至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1583/12237999/1ba55d619df3/fonc-15-1606116-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1583/12237999/e8901f8d8d93/fonc-15-1606116-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1583/12237999/54df69e9fbdd/fonc-15-1606116-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1583/12237999/c29ade4f96e6/fonc-15-1606116-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1583/12237999/28d8fc90ce62/fonc-15-1606116-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1583/12237999/1ba55d619df3/fonc-15-1606116-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1583/12237999/e8901f8d8d93/fonc-15-1606116-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1583/12237999/54df69e9fbdd/fonc-15-1606116-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1583/12237999/c29ade4f96e6/fonc-15-1606116-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1583/12237999/28d8fc90ce62/fonc-15-1606116-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1583/12237999/1ba55d619df3/fonc-15-1606116-g005.jpg

相似文献

1
Rare case report: non-mass invasive ductal carcinoma presenting with rectal and cervical lymph node metastasis as the initial symptom.罕见病例报告:以直肠和宫颈淋巴结转移为首发症状的非肿块型浸润性导管癌。
Front Oncol. 2025 Jun 25;15:1606116. doi: 10.3389/fonc.2025.1606116. eCollection 2025.
2
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
3
Rapid Development of Breast Mass With Recurrent Episodes of Hypoglycemia Should Raise Suspicion of Breast Cancer With Insulinoma: A Case Report.伴有反复低血糖发作的乳腺肿块快速增大应怀疑为乳腺癌合并胰岛素瘤:一例报告
Cancer Rep (Hoboken). 2025 Jun;8(6):e70243. doi: 10.1002/cnr2.70243.
4
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
5
Lateral lymph node dissection combined with endoscopic submucosal dissection for early rectal cancer complicated with ulcerative colitis: A case report.侧方淋巴结清扫联合内镜下黏膜下剥离术治疗合并溃疡性结肠炎的早期直肠癌:1例病例报告
Medicine (Baltimore). 2025 Jul 4;104(27):e43160. doi: 10.1097/MD.0000000000043160.
6
Clinical Practice Updates: AGA Clinical Practice Update on GI Manifestations and Autonomic or Immune Dysfunction in Hypermobile Ehlers-Danlos Syndrome: Expert Review.临床实践更新:美国胃肠病学会关于可弯曲性埃勒斯-当洛综合征的胃肠道表现及自主神经或免疫功能障碍的临床实践更新:专家综述
Clin Gastroenterol Hepatol. 2025 May 19. doi: 10.1016/j.cgh.2025.02.015.
7
A systematic overview of chemotherapy effects in breast cancer.乳腺癌化疗效果的系统综述。
Acta Oncol. 2001;40(2-3):253-81. doi: 10.1080/02841860151116349.
8
Robot assisted sentinel lymph node biopsy using indocyanine green combined with carbon nanoparticles staining improved detection rates in breast cancer.使用吲哚菁绿联合碳纳米颗粒染色的机器人辅助前哨淋巴结活检提高了乳腺癌的检测率。
Sci Rep. 2025 Jul 1;15(1):21366. doi: 10.1038/s41598-025-06338-6.
9
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.

本文引用的文献

1
Distant Metastases of Breast Cancer Resemble Primary Tumors in Cancer Cell Composition but Differ in Immune Cell Phenotypes.乳腺癌的远处转移在癌细胞组成上与原发肿瘤相似,但在免疫细胞表型上有所不同。
Cancer Res. 2025 Jan 2;85(1):15-31. doi: 10.1158/0008-5472.CAN-24-1211.
2
Predicting Non-Mass Breast Cancer Utilizing Ultrasound and Molybdenum Target X-Ray Characteristics.利用超声和钼靶X线特征预测非肿块型乳腺癌
J Multidiscip Healthc. 2024 Sep 2;17:4267-4276. doi: 10.2147/JMDH.S473370. eCollection 2024.
3
Gastrointestinal Metastases From Lobular Breast Carcinoma: A Literature Review.
小叶性乳腺癌的胃肠道转移:文献综述
Cureus. 2024 Jul 31;16(7):e65852. doi: 10.7759/cureus.65852. eCollection 2024 Jul.
4
The Japanese breast cancer society clinical practice guidelines for breast cancer screening and diagnosis, 2022 edition.日本乳腺癌学会乳腺癌筛查和诊断临床实践指南,2022 年版。
Breast Cancer. 2024 Mar;31(2):157-164. doi: 10.1007/s12282-023-01521-x. Epub 2023 Nov 16.
5
Clinical Features and Prognosis of Uncommon Metastatic Breast Cancer: A Retrospective Analysis of 82 Cases.罕见转移性乳腺癌的临床特征和预后:82 例回顾性分析。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231184990. doi: 10.1177/15330338231184990.
6
Role of Surgery in Metastatic Breast Cancer: Insights from a Narrative Review.手术在转移性乳腺癌中的作用:一篇叙述性综述的见解
Breast Cancer (Dove Med Press). 2023 May 9;15:349-358. doi: 10.2147/BCTT.S405864. eCollection 2023.
7
The value of case reports in rare oncological scenarios: mixed method analysis of colorectal metastases from breast cancer.病例报告在罕见肿瘤学情况下的价值:乳腺癌结直肠转移的混合方法分析。
Clin Exp Metastasis. 2023 Jun;40(3):205-216. doi: 10.1007/s10585-023-10207-9. Epub 2023 Apr 27.
8
Breast Cancer Statistics, 2022.2022 年乳腺癌统计数据。
CA Cancer J Clin. 2022 Nov;72(6):524-541. doi: 10.3322/caac.21754. Epub 2022 Oct 3.
9
Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers.细胞角蛋白 7 和细胞角蛋白 20 在癌症中的表达:对 15424 例癌症的组织微阵列研究。
Exp Mol Pathol. 2022 Jun;126:104762. doi: 10.1016/j.yexmp.2022.104762. Epub 2022 Apr 4.
10
Rare sites of breast cancer metastasis: a review.乳腺癌转移的罕见部位:综述
Transl Cancer Res. 2019 Oct;8(Suppl 5):S518-S552. doi: 10.21037/tcr.2019.07.24.